Acute pancreatitis associated with boceprevir: A case report

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 4, 2014, Pages 454-456

  Bilar, Juliana Miguel ^a   Carvalho Filho, Roberto José ^a   Mota, Carolina Frade Magalhães Girardin Pimentel ^a   da Silva Fucuta, Patricia ^a   Ferraz, Maria Lucia Cardoso Gomes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hepatitis C; Protease inhibitor; Side effect

Indexed keywords

AMYLASE; BOCEPREVIR; PEGINTERFERON ALPHA2A; RIBAVIRIN; TRIACYLGLYCEROL LIPASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM ION; HEMOGLOBIN; INTERFERON; PEGINTERFERON ALPHA2B; TRIACYLGLYCEROL;

ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FIBROSIS; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT DURATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VIRUS LOAD; VOMITING; ABDOMINAL NUCLEAR MAGNETIC RESONANCE IMAGING; BRAZIL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FLU LIKE SYNDROME; HEMATOCRIT; LEUKOCYTE; THROMBOCYTE;

HEPATITIS C; PROTEASE INHIBITOR; SIDE EFFECT;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; PANCREATITIS; POLYETHYLENE GLYCOLS; PROLINE; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 84904023852     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2014.03.008     Document Type: Article

References (13)

1. World Health Organization Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 2000, 75:18-19.
2. Manns M.P., McHutchison J.G., Gordon S.C., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001, 358:958-965.
3. Malcolm B.A., Liu R., Lahser F., et al. SCH 503034, a mechanism based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon replicon cells. Antimicrob Agents Chemother 2006, 50:1013-1020.
4. Poordad F., McCone J., Bacon B.R., et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011, 364:1195-1206.
5. Bacon B.R., Gordon S.C., Lawitz E., et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011, 364:1207-1212.
6. Ventura C., Urich R., Skinner S., et al. First report of telaprevir-induced pancreatitis. Dig Dis Sci 2013, 58:887-888.
7. Banks P.A., Freeman M.L. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006, 101:2379-2400.
8. Balani A.R., Grendell J.H. Drug-induced pancreatitis. Incidence, management and prevention. Drug Saf 2008, 31:823-837.
9. Vinklerova I., Prochazka M., Prochazka V., Urbánek K. Incidence, severity and etiology of drug-induced acute pancreatitis. Dig Dis Sci 2010, 55:2977-2981.
10. Nitsche C., Maertin S., Scheiber J., Ritter C.A., Lerch M.M., Mayerlel J. Drug-induced pancreatitis. Curr Gastroenterol Rep 2012, 12:128-131.
11. Karch F.E., Lasagna L. Adverse drug reactions: a critical review. JAMA 1975, 234:1236-1241.
12. Mallory A., Kern F. Drug induced pancreatitis: a critical review. Gastroenterology 1980, 78:813-820.
13. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reaction. Clin Pharm Ther 1981, 30:239-245.